Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr;31(4):2192-2193.
doi: 10.1245/s10434-024-14903-y. Epub 2024 Jan 25.

Evolution of Surgical Management and Outcomes of Neuroendocrine Tumor Liver Metastases

Ricardo J Bello  1 , Callisia N Clarke  2
Affiliations
Editorial

Evolution of Surgical Management and Outcomes of Neuroendocrine Tumor Liver Metastases

Ricardo J Bello et al. Ann Surg Oncol. 2024 Apr.
No abstract available

PubMed Disclaimer

References

    1. Gudmundsdottir H, Habermann EB, Vierkant RA, et al. Survival and symptomatic relief after cytoreductive hepatectomy for neuroendocrine tumor liver metastases: long-term follow-up evaluation of more than 500 patients. Ann Surg Oncol. 2023;30(8):4840–51. https://doi.org/10.1245/s10434-023-13372-z . - DOI - PubMed - PMC
    1. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197(1):29–37. - DOI - PubMed
    1. Fairweather M, Swanson R, Wang J, et al. Management of neuroendocrine tumor liver metastases: long-term outcomes and prognostic factors from a large prospective database. Ann Surg Oncol. 2017;24(8):2319–25. - DOI - PubMed
    1. Scott AT, Breheny PJ, Keck KJ, et al. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs). Surgery. 2019;165(1):166–75. - DOI - PubMed

Publication types

LinkOut - more resources